Yu‐Ju Chen
- Spectroscopy top 0.2%
- Advanced Proteomics Techniques and Applications 60
- Mass Spectrometry Techniques and Applications 40
- Molecular Biology top 1%
- Glycosylation and Glycoproteins Research 33
- Advanced biosensing and bioanalysis techniques 22
- Metabolomics and Mass Spectrometry Studies 21
- RNA modifications and cancer 14
- Cancer Research top 2%
- Cell Biology top 2%
- Immunology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 21
-
- Peptidase Inhibition and Analysis 13
Yu‐Ju Chen
350 papers receiving 9.5k citations
Hit Papers
Peers
Comparison fields: 5 of 205
- Spectroscopy 1.8k
- Molecular Biology 5.5k
- Cancer Research 686
- Cell Biology 645
- Immunology 825
Countries citing papers authored by Yu‐Ju Chen
This map shows the geographic impact of Yu‐Ju Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ju Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ju Chen more than expected).
Fields of papers citing papers by Yu‐Ju Chen
This network shows the impact of papers produced by Yu‐Ju Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ju Chen. The network helps show where Yu‐Ju Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yu‐Ju Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 29 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 0 | |
| 10 | Streamlined single-cell proteomics by an integrated microfluidic chip and data-independent acquisition mass spectrometrybreakdown → | 2022 | 136 |
| 11 | 2021 | 30 | |
| 12 | 2021 | 1 | |
| 13 | 2020 | 5 | |
| 14 | 2019 | 17 | |
| 15 | 2017 | 26 | |
| 16 | 2017 | 59 | |
| 17 | Chinese Relation Extraction by Multiple Instance Learning | 2016 | 8 |
| 18 | 2014 | 85 | |
| 19 | 2011 | 51 | |
| 20 | 2005 | 22 |
About Yu‐Ju Chen
Yu‐Ju Chen is a scholar working on Spectroscopy, Molecular Biology and Aging, having authored 372 papers that have together received 9.7k indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (60 papers), Mass Spectrometry Techniques and Applications (40 papers), Glycosylation and Glycoproteins Research (33 papers), Advanced biosensing and bioanalysis techniques (22 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Metabolomics and Mass Spectrometry Studies (21 papers), RNA modifications and cancer (14 papers) and Peptidase Inhibition and Analysis (13 papers). The work is most often cited by research in Spectroscopy (1.8k citations), Molecular Biology (5.5k citations) and Cancer Research (686 citations). Yu‐Ju Chen has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Yi‐Ju Chen, Chun‐Cheng Lin, Yi‐Ting Wang, Po‐Chiao Lin, Jen Liou, Chia‐Li Han, Chia‐Feng Tsai, Mei‐Chun Tseng, Tzong-Yi Lee and Rey‐Chue Hwang. Their work appears in journals such as Journal of Proteome Research, Analytical Chemistry, Molecular & Cellular Proteomics, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.